RAIMONDI, Maria Valeria
 Distribuzione geografica
Continente #
NA - Nord America 8.636
EU - Europa 5.600
AS - Asia 4.157
SA - Sud America 693
AF - Africa 165
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.259
Nazione #
US - Stati Uniti d'America 8.472
IT - Italia 1.723
SG - Singapore 1.412
RU - Federazione Russa 1.349
CN - Cina 1.108
BR - Brasile 553
FI - Finlandia 523
HK - Hong Kong 436
DE - Germania 421
VN - Vietnam 405
UA - Ucraina 313
PL - Polonia 263
FR - Francia 235
IE - Irlanda 188
GB - Regno Unito 186
JP - Giappone 157
IN - India 124
SE - Svezia 110
CA - Canada 85
KR - Corea 81
BD - Bangladesh 62
IQ - Iraq 56
CI - Costa d'Avorio 54
TR - Turchia 53
AR - Argentina 50
NL - Olanda 48
MX - Messico 46
AT - Austria 44
BE - Belgio 40
RO - Romania 38
ZA - Sudafrica 36
UZ - Uzbekistan 31
IR - Iran 26
ID - Indonesia 23
MY - Malesia 22
PK - Pakistan 21
TW - Taiwan 19
EC - Ecuador 18
ES - Italia 18
CH - Svizzera 17
VE - Venezuela 17
CL - Cile 15
MA - Marocco 15
PH - Filippine 15
CZ - Repubblica Ceca 14
EG - Egitto 14
JO - Giordania 14
SA - Arabia Saudita 14
KE - Kenya 12
PY - Paraguay 12
NP - Nepal 11
SK - Slovacchia (Repubblica Slovacca) 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 9
TN - Tunisia 9
AL - Albania 8
AZ - Azerbaigian 8
JM - Giamaica 8
PE - Perù 8
UY - Uruguay 8
CO - Colombia 7
GR - Grecia 7
HU - Ungheria 7
PT - Portogallo 7
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
IL - Israele 5
PS - Palestinian Territory 5
SN - Senegal 5
TH - Thailandia 5
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
NG - Nigeria 4
TT - Trinidad e Tobago 4
AU - Australia 3
CG - Congo 3
EE - Estonia 3
LK - Sri Lanka 3
LT - Lituania 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
Totale 19.238
Città #
Ashburn 1.193
Singapore 942
Fairfield 812
Chandler 515
Palermo 499
Woodbridge 483
San Jose 445
Ann Arbor 411
Hong Kong 398
Wilmington 372
Houston 366
Cambridge 327
Seattle 317
Zgierz 232
Beijing 199
Moscow 199
Dublin 178
Jacksonville 161
Medford 156
Council Bluffs 153
Dallas 147
Tokyo 146
Los Angeles 136
Ho Chi Minh City 134
Nanjing 126
Santa Clara 124
Des Moines 106
The Dalles 106
Hanoi 105
Princeton 100
Lauterbourg 97
New York 96
Helsinki 91
Frankfurt am Main 87
Altamura 85
Milan 74
San Diego 69
Dearborn 67
Rome 61
Buffalo 56
Hefei 55
Lawrence 55
Abidjan 53
Boardman 49
Tulsa 48
Chicago 46
São Paulo 43
Ludwigshafen am Rhein 42
Jinan 40
Tianjin 39
London 37
Shenyang 34
Hebei 31
Orem 28
Nuremberg 27
Zhengzhou 27
Brussels 25
Guangzhou 25
Venice 24
Berlin 23
Vienna 23
Columbus 22
Johannesburg 22
Montreal 22
Napoli 22
Redwood City 22
Shanghai 22
Tashkent 22
Catania 21
Changsha 21
Jiaxing 21
Nanchang 21
Ningbo 21
Saint Petersburg 20
Washington 20
Da Nang 19
Naples 19
Phoenix 19
Atlanta 18
Seongnam 18
Andover 17
Curitiba 17
Haiphong 17
Redondo Beach 17
New Delhi 16
Paris 16
Rio de Janeiro 16
Stockholm 16
Toronto 16
Chennai 15
Mumbai 15
Ottawa 15
Warsaw 15
Amman 14
Baghdad 14
Kumar 14
Kuala Lumpur 13
Munich 13
Piscataway 13
Poplar 13
Totale 11.839
Nome #
Composizione e attività biologica di “idrolati” di agrumi 350
N-(INDAZOLYL)BENZAMIDO DERIVATIVES AS CDK1 INHIBITORS: DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY, AND MOLECULAR DOCKING STUDIES 300
Discovery of a new class of sortase a transpeptidase inhibitors to tackle gram-positive pathogens: 2-(2-phenylhydrazinylidene)alkanoic acids and related derivatives 296
4-Diazopyrazole Derivatives as Potential New Antibiofilm Agents 294
2-Cinnamamido, 2-(3-phenylpropiolamido), and 2-(3-phenylpropanamido)benzamides: synthesis, antiproliferative activity, and mechanism of action 281
Anthranilamide-based 2-phenylcyclopropane-1-carboxamides, 1,1'-biphenyl-4-carboxamides and 1,1'-biphenyl-2-carboxamides: Synthesis biological evaluation and mechanism of action 281
DHFR inhibitors: Reading the past for discovering novel anticancer agents 273
Current development of CFTR potentiators in the last decade 265
Comparative studies of the Pschorr reaction in the pyrazole series. Access to the new dibenzo(e,g)pyrazolo(1,5-a)(1,3)diazocine system of pharmaceutical interest 256
Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds 253
2-cinnamamido, 2-(3-phenylpropiolamido) and 2-(3-phenylpropanamido)benzamides: synthesis, antiproliferative activity and mechanism of action 246
Comparative Structural Studies of 4-Diazopyrazole Derivatives by X-Ray Diffraction and Theoretical Investigation 241
THE ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTIRETROVIRAL THERAPY 239
NEW 4-DIAZOPYRAZOLE DERIVATIVES AS POTENTIAL ANTIBIOFILM AGENTS 237
Synthesis and antiproliferative activity of 3-(2-cloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-one 236
Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation 234
Synthesis and anti-staphylococcal activity of new 4-diazopyrazole derivatives 233
Synthesis and Anti-Staphylococcal Activity of New Halogenated Pyrroles Related to Pyrrolomycins F 227
A new class of phenylhydrazinylidene derivatives as inhibitors of Staphylococcus aureus biofilm formation 227
Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides 224
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF 3-AMINO-N-PHENYL-1H-INDAZOLE-1-CARBOXAMIDES 222
The Reactivity of 4’-Substituted Spiro[Isoindole-1,3’-pyrazoles] Derivatives: Substitution/Elimination Reactions and Access to Biaryl Derivatives 221
5-Amino-1-phenyl-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid 217
Bioactive pyrrole-based compounds with target selectivity 216
Pyrrolomycins as potential anti-staphylococcal biofilms agents 213
SYNTHESIS AND IN VITRO ANTILEUKEMIC ACTIVITY OF NEW 4-TRIAZENOPYRAZOLE DERIVATIVES 211
Synthesis of alkyl-5,8-dimethyl-6-phenyl-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-ones of pharmaceutical interest 210
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides 207
Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle 206
SINTESI ED ATTIVITÀ ANTINEOPLASTICA DI NUOVI COMPOSTI ETEROCICLICI 205
In vitro anti-Gram-positive and anti-staphylococcal biofilm activity of newly halogenated pyrroles related to Pyrrolomycins 204
Rivalutazione degli Idrolati dell’industria agrumaria siciliana. 204
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one 202
Isoxazolo[3,4-d]pyridazin-7(6H)-one derivatives endowed with anti-proliferative Activity. 200
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity 198
Pyrrolomycins as antimicrobial agents. Microwave-assisted organic synthesis and insights into their antimicrobial mechanism of action 198
Novel Sortase A Inhibitors to Counteract Gram-Positive Bacterial Biofilms 198
Antileukemic activity of some new 3-amino-N-phenyl-(1H)-indazole-1-carboxamide derivatives 193
Synthesis and antimicrobial activity of new bromine-rich pyrrole derivatives related to monodeoxypyoluteorin 193
New Anti-Adhesion Agents In The Development of Antivirulence Drugs 192
Discovery of a New Class of Sortase A Transpeptidase Inhibitors to Tackle Gram-positive Pathogens: 2-Phenylhydrazonoalkanoic Acid Derivatives 189
Synthesis and biological evaluation of new indazole derivatives 188
CDK: LigandFit Enrichment Plot of Active Compounds in a Screening Dataset. 184
Antibiofilm activity of a novel pyrrolomycin against staphylococcal biofilms of veterinary interest 184
Progettazione e sintesi di nuovi complessi metallici potenziali inibitori di FGFR4 184
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 181
Non-Classical Transformation of Benzendiazonium Hydrogen Sulfates. Access to 1,3-Dimethylisochromeno[4,3-c]pyrazol-5(1H)-one, a Potential Benzodiazepine Receptor Ligand 181
Pharmaceutical potential of synthetic and natural pyrrolomycins 181
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors 180
The role of (E)-6-chloro-3-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-2-styrylquinazolin-4(3H)-one in the modulation of cannabinoidergic system. A pilot study 177
Progettazione e sintesi di nuovi derivati 4-chinazolinonici potenziali inibitori della diidrofolato reduttasi 176
Biofilm capability of staphylococcus strains isolated from food and the anti-biofilm activity of a chemically synthesized pyrrolomycin 172
GPCR Inhibition in Treating Lymphoma 169
Design of copper(II) complexes as potential anticancer prodrugs 168
PEG 400/Cerium Ammonium Nitrate Combined with Microwave-Assisted Synthesis for Rapid Access to Beta-Amino Ketones. An Easy-to-Use Protocol for Discovering New Hit Compounds 168
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells 167
Synthesis and antiproliferative activity of new derivatives containing the polycyclic system 5,7:7,13-dimethanopyrazolo[3,4-b]pyrazolo[3’,4’:2,3]azepino[4,5-f]azocine 166
DESIGN AND SYNTHESIS OF NEW QUINAZOLIN-4(3H)-ONE HYBRIDS AS DUAL INHIBITORS OF TUBULIN AND DIHYDROFOLATE REDUCTASE 166
New Synthetic Nitro-Pyrrolomycins as Promising Antibacterial and Anticancer Agents 166
Derivati policiclici con struttura complessa dotati di attività antiproliferativa 162
Pyrrolo[2',3':3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 162
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF TRIAZENOINDAZOLES AND TRIAZENOPYRAZOLES: A COMPARATIVE STUDY 161
Synthesis, benzodiazepine receptor binding and molecular modelling of isochromeno[4,3-c]pyrazol-5(1H)-one derivatives 160
ATTIVITÀ ANTIPROLIFERATIVA DI UN DERIVATO POLICICLICO CON STRUTTURA COMPLESSA 160
Synthesis and biofilm formation reduction of pyrazole-4-carboxamide derivatives in some Staphylococcus aureus strains 160
Pirrolomicine che inibiscono la Sortasi A nelle infezioni sostenute da batteri Gram-positivi 160
Sintesi di un isostero del 3,5-dimetil-6-fenil-8-(trifluorometil)-5,6-diidropirazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one (CF3-TZP) con potenziale attività biologica 158
Pyrazolo[3,4-d]pyrimidine Derivatives as COX-2 Selective Inhibitors: Synthesis and Molecular Modelling Studies 154
Novel chemical countermeasures against staphylococcal biofilms 154
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis 150
Synthesis and antiproliferative activity of a natural like glycoconjugate polycyclic compound 150
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-trifluoromethyl-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-one 149
Recent discoveries of anticancer flavonoids 147
Sortase A Inhibitors: Recent Advances and Future Perspectives 146
SYNTHESIS AND BIOLOGICAL EVALUATION OF 2-PHENYL-3-[INDAZOL-3-YL]-4(3H)-QUINAZOLINONES 144
New complex polycyclic compounds: Synthesis, antiproliferative activity and mechanism of action 144
Editorial: Emerging heterocycles as bioactive compounds 141
Synthesis and anticancer activity of 3-amino-N-phenyl-1H-indazole-1-carboxamide and 1-(1H)indazol-3-yl-3-phenylureido derivatives 140
Synthesis, antiproliferative activity and possible mechanism of action of novel 2-acetamidobenzamides bearing the 2-phenoxy functionality 138
THE KEY ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTICANCER THERAPIES: A PILOT STUDY IN THE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER 137
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamide derivatives 136
Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells 136
NUOVI DERIVATI 2-ACETAMMIDOBENZAMMIDICI: ATTIVITÀ ANTIPROLIFERATIVA E POSSIBILE MECCANISMO DI AZIONE 131
Synthesis of New Indazol-3-yl derivatives as CDK1 inhibitors 130
Synthesis and antirpoliferative activity of isoxazolo[3,4-d]pyridazin-7(6H)-one derivatives 130
Synthesis, antiproliferative activity, and mechanism of action of new benzamido derivatives 129
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors 128
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma 127
Synthesis and antiproliferative activities of two new analogs of tetrazepinones 127
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel 125
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis 117
Pyrrolomycins as novel agents against staphylococcal biofilms 115
Reazioni consecutive di Pschorr e Sandmeyer non classiche in serie isossazolica. Accesso a composti di interesse farmaceutico 114
Synthesis and antiproliferative activity of a natural like glucosyl polycyclic compound 114
Synthesized benzamido derivatives exert antiproliferative effects by DNA damage and ROS generation. 114
Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity 114
Sintesi e valutazione biologica di nuovi nitroderivati analoghi della pirrolomicina D attivi su Pseudomonas aeruginosa 112
Synthesis and Antiproliferative Activity of a New Pyrazolo[3,4-f]1,2,3,5-tetrazepin-4(3H)-one Derivative 111
Synthesis and antiproliferative activity of indazole derivatives 110
Synthesis and biological evaluation of new 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides 108
Totale 18.255
Categoria #
all - tutte 68.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 0 110 132
2021/20221.454 113 285 44 46 74 43 57 94 171 174 74 279
2022/20231.689 183 269 36 162 195 253 105 112 193 53 94 34
2023/2024922 44 118 35 147 66 144 105 72 11 28 32 120
2024/20252.345 76 179 102 221 118 94 248 150 162 231 326 438
2025/20267.378 583 207 543 627 696 1.156 1.133 810 564 785 274 0
Totale 20.064